Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 21;17(27):3229-34.
doi: 10.3748/wjg.v17.i27.3229.

Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study

Affiliations

Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study

Chang-Zheng Du et al. World J Gastroenterol. .

Abstract

Aim: To evaluate the oncologic outcomes of primary and post-irradiated early stage rectal cancer and the effectiveness of adjuvant chemotherapy for rectal cancer patients.

Methods: Eighty-four patients with stage I rectal cancer after radical surgery were studied retrospectively and divided into ypstage I group (n = 45) and pstage I group (n = 39), according to their preoperative radiation, and compared by univariate and multivariate analysis.

Results: The median follow-up time of patients was 70 mo. No significant difference was observed in disease progression between the two groups. The 5-year disease-free survival rate was 84.4% and 92.3%, respectively (P = 0.327) and the 5-year overall survival rate was 88.9% and 92.3%, respectively, for the two groups (P = 0.692). The disease progression was not significantly associated with the pretreatment clinical stage in ypstage I group. The 5-year disease progression rate was 10.5% and 19.2%, respectively, for the patients who received adjuvant chemotherapy and for those who rejected chemotherapy in the ypstage I group (P = 0.681).

Conclusion: The oncologic outcomes of primary and post-irradiated early stage rectal cancer are similar. Patients with ypstage I rectal cancer may slightly benefit from adjuvant chemotherapy.

Keywords: Neoadjuvant radiotherapy; Rectal cancer; Total mesorectal excision.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Five-year disease-free survival rate for patients in two groups.
Figure 2
Figure 2
Five-year overall survival rate for patients in two groups.

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
    1. Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol. 2005;11:4685–4688. - PMC - PubMed
    1. Meredith KL, Hoffe SE, Shibata D. The multidisciplinary management of rectal cancer. Surg Clin North Am. 2009;89:177–215, ix-x. - PubMed
    1. Sebag-Montefiore D, Bujko K, Valentini V. Rectal cancer multidisciplinary management: evidences and future landscape. Radiother Oncol. 2009;92:145–147. - PubMed
    1. Wille-Jørgensen P, Bülow S. The multidisciplinary team conference in rectal cancer--a step forward. Colorectal Dis. 2009;11:231–232. - PubMed

Substances